Inoviq Ltd has released a press release.
Exo-oc program completes serum equivalence study
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- INOVIQ Investor Briefing
- Appendix 4C and Quarterly Activities Report - June 2023
- INOVIQ and Promega announce Global Joint Marketing Agreement
- SubB2M/CA15.3 Clinical Validation Data Investor Presentation
- Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
Later from Inoviq
- IIQ and ResearchDx sign USA EXO-NET Services Agreement
- ASX Small and Mid-Cap Conference Investor Presentation
- Appendix 4C and Quarterly Activities Report - September 2023
- ANSEV Meeting Presentations
- Bell Potter Healthcare Conference Investor Presentation
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq